The Options Are Getting Better — And That Is Good News for Everyone
If you are already on a GLP-1 and happy with your results, this article is good context. If you are still on the sidelines, it is a reason for optimism: the medications of tomorrow will be more effective, more convenient, and likely more affordable than what exists today.
What Is Already Here (2026)
| Drug | Type | Key Feature |
|---|---|---|
| Wegovy pill | Oral, daily | First oral GLP-1 for weight loss ($149/mo) |
| Orforglipron | Oral, daily | No food/water restrictions ($149/mo) |
| Wegovy HD 7.2mg | Injectable, weekly | Highest semaglutide dose (20.7% avg loss) |
What Is Coming Next
CagriSema (Novo Nordisk) — Combines semaglutide with an amylin analog called cagrilintide. Clinical trials showed about 23% weight loss. Filed with the FDA; expected U.S. launch in early 2027. This could be the most effective injectable option from Novo Nordisk yet.
Retatrutide (Eli Lilly) — A "triple agonist" targeting three receptors (GLP-1, GIP, and glucagon) instead of one or two. Phase 3 data showed up to 24-26% weight loss. Not yet FDA-approved, but submission expected in late 2026 or 2027. This is the most aggressive weight-loss drug in the pipeline.
Survodutide (Boehringer Ingelheim) — A dual GLP-1/glucagon agonist with a unique angle: it also shows promise for liver disease (MASH). For patients whose weight has affected their liver health, this could be a two-for-one medication. Phase 3 is ongoing.
Elecoglipron (AstraZeneca) — Another oral GLP-1, just entering Phase 3. In early trials, 90% of diabetes patients reached healthy blood sugar targets. Adds a third oral option to the pipeline, which means more competition and eventually lower prices for everyone.
You do not need to wait.
The medications available today are already highly effective. Starting treatment now means you are already improving your health while even better options are on the horizon. You can always switch later if a new drug is a better fit.
Start with What's Available Today
Current GLP-1 medications deliver real results. Explore your options when you're ready.
Compare Providers →